On July 27, 2026, CRC1709 was pleased to welcome Prof. Brian Huntly from the University of Cambridge for a day of scientific exchange focused on acute myeloid leukaemia, gene regulation, and academic career development. In addition to his invited speaker…
As part of the CRC1709 Invited Speaker Series, we are pleased to welcome Prof. Brian Huntly from the University of Cambridge. In his lecture, “Dissecting downstream gene regulatory circuits in AML via critical TF interrogation,” Prof. Huntly will present his…
CRC 1709 postdoctoral researcher Enise Ceran is the first author of a new study published in Blood, demonstrating how single-cell measurable residual disease (scMRD) profiling can identify patients with acute myeloid leukemia (AML) who are most likely to benefit from…
